People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination
Murat Gainullin(Oslo University Hospital), Ludvig A. Munthe(Oslo University Hospital), Amin Alirezaylavasani(Norwegian University of Science and Technology), Lorenzo Federico(Oslo University Hospital), Hina Anjum, Hassen Kared(Singapore Immunology Network), Viktoriia Chaban(Oslo University Hospital), Jon-Aksel Jacobsen, Trevor Clancy(Inholland University of Applied Sciences), Simen Tennøe, Richard Stratford, Linda Elise Couëssurel Wüsthoff(Oslo University Hospital), Kathleen Henriksen(University of Oslo), Gull Wildendahl, Julie Røkke Osen(Oslo University Hospital), Fridtjof Lund‐Johansen(Oslo University Hospital), Brandon Malone, John Torgils Vaage(University of Oslo)
Cited by 0
Related Papers
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
|Journal of Clinical Investigation|2021|276
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
|Clinical Cancer Research|2018|195
Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
|The Journal of Cell Biology|2010|165
Remodeling of secretory lysosomes during education tunes functional potential in NK cells
|Nature Communications|2019|129